Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Share Option Grants

4 Jun 2010 13:10

RNS Number : 1021N
Cello Group plc
04 June 2010
 



Cello Group plc

4 June 2010

 

Cello Group plc ("Cello" or the "Company")

 

Share Option Grants

 

The Group today announces awards under its option schemes as follows:

 

Under the Cello Group plc HM Revenue and Customs Approved Share Option Plan 2009 ("Approved Plan") and under the Cello Group plc Unapproved Share Option Plan 2010 ("Unapproved Plan") options were granted on 4 June 2010 entitling certain employees and directors to acquire a total of 1,959,000 ordinary shares of 10 pence each ("Ordinary Share") at an exercise price of 31.5 pence per Ordinary Share.

 

As announced on March 16, the Board of Cello had intended not to grant any further awards under the Performance Share Plan ("PSP") and was in the process of finalising a Joint Ownership Share Plan ("JOSP"). The Board has now decided not to adopt a JOSP and instead to reinstate the PSP, renamed the Cello Group plc Performance Share Plan 2010, with new performance conditions based on Total Shareholder Return relative to a comparator group of the company's peers, as the principal long term incentive plan for its most senior employees.

 

Under the PSP, options were granted on 4 June 2010 entitling certain directors and employees to acquire a total of 1,040,000 ordinary shares of 10 pence each ("Ordinary Share") at an exercise price of 10 pence per Ordinary Share.

 

The following directors were awarded options under the Approved Plan and the PSP on 4 June 2010.

 

Mark Scott was awarded options over 72,000 shares under the Approved Plan and options over 430,000 shares under the PSP. These shares represent a total of 0.82% of the company's total issued share capital. Mark Bentley was awarded options over 72,000 shares under the Approved Plan and options over 214,000 shares under the PSP. These shares represent a total of 0.47% of the company's total issued share capital.

 

All these options will normally be exercisable from 4 June 2013 subject to continued employment and the extent to which performance conditions have been met.

 

4 June 2010

 

Enquiries:

 

Cello Group plc

 

Mark Bentley, Group Finance Director 020 7812 8463

 

Altium

 

Paul Chamberlain 020 7484 4040

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFIFRIISIII
Date   Source Headline
20th Jul 202012:21 pmRNSForm 8.3 - Cello Health Plc
17th Jul 20209:14 amRNSForm 8.3 - Cello Health PLC
16th Jul 20205:00 pmRNSForm 8.3 - Cello Health plc
16th Jul 20208:48 amRNSForm 8.3 - Cello Health PLC
16th Jul 20207:00 amRNSForm 8.3 - Cello Health Plc
15th Jul 20203:00 pmRNSUpdate re: antitrust clearances
15th Jul 20201:44 pmRNSForm 8.3 - Cello Health Plc
15th Jul 20201:21 pmRNSHolding(s) in Company
15th Jul 20208:55 amRNSForm 8.3 - Cello Health PLC
14th Jul 20201:33 pmRNSForm 8.3 - Cello Health plc
14th Jul 20208:51 amRNSForm 8.3 - Cello Health PLC
14th Jul 20208:04 amRNSHolding(s) in Company
14th Jul 20207:01 amRNSHolding(s) in Company
13th Jul 20203:15 pmBUSForm 8.3 - Cello Health plc
13th Jul 202010:51 amBUSForm 8.3 - CELLO HEALTH PLC
13th Jul 20208:18 amRNSForm 8.3 - Cello Health PLC
13th Jul 20207:00 amRNSHolding(s) in Company
13th Jul 20207:00 amRNSPublication of Scheme Document
10th Jul 20203:20 pmRNSForm 8.3 - Cello Health Plc
10th Jul 20203:17 pmRNSForm 8.3 - Cello Health PLC
10th Jul 20203:10 pmPRNForm 8.3 - Cello Health Plc
10th Jul 20201:34 pmBUSForm 8.3 - CELLO HEALTH PLC
10th Jul 202010:11 amRNSHolding(s) in Company
10th Jul 20209:41 amRNSForm 8.3 - Cello Health Plc
10th Jul 20208:51 amRNSForm 8.3 - Cello Health PLC
9th Jul 20206:20 pmRNSUpdate on letters of intent
9th Jul 20205:38 pmRNSHolding(s) in Company
9th Jul 20203:20 pmRNSForm 8.3 - Cello Health
9th Jul 20203:17 pmRNSForm 8.3 - CELLO HEALTH PLC
9th Jul 20203:08 pmRNSForm 8.3 - Cello Health PLC
9th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
9th Jul 202012:33 pmRNSHolding(s) in Company
9th Jul 202011:31 amRNSForm 8.3 - Cello Health Plc
9th Jul 20209:20 amRNSForm 8.3 - Cello Health plc
9th Jul 20209:10 amRNSForm 8.3 - Cello Health PLC
9th Jul 20207:00 amRNSUpdate on irrevocable undertakings
8th Jul 20203:56 pmPRNForm 8.3 - Cello Health Plc
8th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
8th Jul 20202:00 pmRNSForm 8.3 - Cello Health Plc
8th Jul 202012:45 pmRNSForm 8.3 - Cello Health plc
8th Jul 202010:35 amRNSForm 8.3 - Cello Health PLC
8th Jul 20209:55 amRNSForm 8.3 - Cello Health plc
8th Jul 20208:54 amPRNForm 8.3 - Cello Health plc
8th Jul 20207:00 amRNSUpdate on irrevocable undertakings
8th Jul 20207:00 amRNSForm 8.3 - Cello Health PLC
7th Jul 20203:20 pmRNSForm 8.3 - Cello Health
7th Jul 20203:19 pmRNSForm 8.3 - CELLO HEALTH PLC
7th Jul 20203:00 pmBUSForm 8.3 - Cello Health Plc
7th Jul 202010:08 amRNSCELLO HEALTH PLC
7th Jul 20209:16 amPRNForm 8.3 - Cello Health Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.